Willkommen auf der Website von Ci3 - Cluster für individualisierte Immunintervention

Featured Article

Advancing precision medicine in the digital age requires solutions developed in the IT and software sector, e.g. big data, machine learning, IT security, data protection, and cross-enterprise collaboration. The PERMIDES project aims at bringing together SMEs from the bio-pharmaceutical and IT sector to advance precision medicine through the development of novel digital solutions along the biopharmaceutical value chain. SMEs participating in the PERMIDES project can increase competitiveness and benefit from an innovation voucher scheme that will provide up to EUR 60,000 per project. About 90 innovation projects will be supported by the voucher scheme.

Featured Events

Teaser Munich Biomarker Conference
29. November 2016 bis 30. November 2016

BioM, die Netzwerkagentur für die Biotechnologie-Branche in München und Bayern, veranstaltet die 6th Munich Biomarker Conference. Die diesjährigen Kernthemen werden die klinische Praxis sowie zielgerichtete Therapien in der personalisierten Medizin sein.

16. Januar 2017

Why join? In 2017, the PERMIDES consortium will publish a call for proposals in order to support biopharma SMEs which can benefit from innovation vouchers of up to EUR 60.000 for the development and implementation of novel IT based solutions for biopharmaceutical R&D challenges. By discussing your IT related needs (from biopharma side) and potential solutions (from IT side) you can help to ensure that the call matches your requirements.


Wir vernetzen Partner aus Pharma, Biotech und Wissenschaft.

Im Mittelpunkt der Ci3 Strategie steht die Entwicklung patientenindividueller Immuntherapeutika und -diagnostika.

Entwicklung, Umsetzung und Koordination der Ci3 Strategie erfolgen durch den Ci3 e.V. und die Ci3 Management Gesellschaft.

supported by: